{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:11:52Z","timestamp":1791479512404,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11102-015-0640-y","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T11:30:17Z","timestamp":1422876617000},"page":"195-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Quality of life in Cushing\u2019s syndrome"],"prefix":"10.1007","volume":"18","author":[{"given":"Alicia","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Aulinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Resmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Valassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"640_CR1","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1530\/EJE-13-0534","volume":"169","author":"O Ragnarsson","year":"2013","unstructured":"Ragnarsson O, Johannsson G (2013) Cushing\u2019s syndrome: a structured short- and long-term management plan for patients in remission. Eur J Endocrinol 169:R139\u2013R152","journal-title":"Eur J Endocrinol"},{"key":"640_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.endonu.2013.03.008","volume":"61","author":"A Aulinas","year":"2014","unstructured":"Aulinas A, Valassi E, Webb SM (2014) Prognosis of patients treated for Cushing syndrome. Endocrinol Nutr 61:52\u201361","journal-title":"Endocrinol Nutr"},{"key":"640_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11102-013-0484-2","volume":"17","author":"X Badia","year":"2014","unstructured":"Badia X, Valassi E, Roset M, Webb SM (2014) Disease-specific quality of life evaluation and its determinants in Cushing\u2019s syndrome: What have we learnt? Pituitary 17:187\u2013195","journal-title":"Pituitary"},{"key":"640_CR4","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s11136-013-0396-7","volume":"22","author":"X Badia","year":"2013","unstructured":"Badia X, Roset M, Valassi E, Franz H, Forsythe A, Webb SM (2013) Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing\u2019s syndrome (ERCUSYN). Qual Life Res 22:2941\u20132950","journal-title":"Qual Life Res"},{"key":"640_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40271-013-0010-7","volume":"6","author":"M Roset","year":"2013","unstructured":"Roset M, Badia B, Forsythe A, Webb SM (2013) CushingQoL Dev Grg. Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing\u2019s syndrome. Patient Patient Cent Outcome Res 6:103\u2013111","journal-title":"Patient Patient Cent Outcome Res"},{"key":"640_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40271-013-0012-5","volume":"6","author":"LM Nelson","year":"2013","unstructured":"Nelson LM, Forsythe A, McLeod L, Pulgar S, Maldonado M, Coles T, Zhang Y, Webb SM, Badia X (2013) Psychometric evaluation of the Cushing\u2019s quality-of-life questionnaire. Patient Patient Cent Outcome Res 6:113\u2013124","journal-title":"Patient Patient Cent Outcome Res"},{"key":"640_CR7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000355622","volume":"98","author":"M Milian","year":"2013","unstructured":"Milian M, Honegger J, Teufel P, Wolf A, Psaras T (2013) Tuebingen CD-25 is a sensitive tool to investigate health-related quality of life in Cushing\u2019s disease patients in the course of the disease. Neuroendocrinol 98:188\u2013199","journal-title":"Neuroendocrinol"},{"key":"640_CR8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-12-1078","volume":"168","author":"SB Abraham","year":"2013","unstructured":"Abraham SB, Abel BS, Rubino D, Nansel T, Ramsey S, Nieman LK (2013) A direct comparison of quality of life in obese and Cushing\u2019s syndrome patients. Eur J Endocrinol 168:787\u2013793","journal-title":"Eur J Endocrinol"},{"key":"640_CR9","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1097\/MJT.0b013e318255bc07","volume":"21","author":"AL Arregger","year":"2014","unstructured":"Arregger AL, Cardoso EML, Sandoval OB, Monardes Tumilasci EG, Sanchez R, Contreras LN (2014) Hormonal secretion and quality of life in Nelson syndrome and Cushing disease after long acting repeatable octreotide: a short series and update. Am J Ther 21:E110\u2013E116","journal-title":"Am J Ther"},{"key":"640_CR10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-13-1013","volume":"171","author":"SM Webb","year":"2014","unstructured":"Webb SM, Ware JE, Forsythe A, Yang M, Badia X, Nelson LM, Signorovitch JE, McLeod L, Maldonado M, Zgliczynski W, de Block C, Portocarrero-Ortiz L, Gadelha M (2014) Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing\u2019s disease. Eur J Endocrinol 171:89\u201398","journal-title":"Eur J Endocrinol"},{"key":"640_CR11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-14-0371","volume":"171","author":"A Santos","year":"2014","unstructured":"Santos A, Resmini E, Crespo I, Pires P, Vives-Gilabert Y, Granell E, Valassi E, G\u00f3mez-Anson B, Mart\u00ednez-Mombl\u00e1n MA, Matar\u00f3 M, Webb SM (2014) Small cerebellar cortex volume in patients with active Cushing\u2019s syndrome. Eur J Endocrinol 171:461\u2013469","journal-title":"Eur J Endocrinol"},{"key":"640_CR12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-13-0471","volume":"169","author":"CD Andela","year":"2013","unstructured":"Andela CD, van der Werff SJA, Pannekoek JN, van den Berg SM, Meijer C, Buchem MA, Rombouts SARB, van der Mast RC, Romijn JA, Tiemensma J, Biermasz NR, van der Wee NJA, Pereira AM (2013) Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing\u2019s disease: a case\u2013control study. Eur J Endocrinol 169:811\u2013819","journal-title":"Eur J Endocrinol"},{"key":"640_CR13","first-page":"75","volume":"39","author":"L Curto","year":"2014","unstructured":"Curto L, Ferrau F, Trimarchi F (2014) Health-related quality of life in patients with Cushing\u2019s syndrome. Minerva Endocrinol 39:75\u201377","journal-title":"Minerva Endocrinol"},{"key":"640_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/EJE-14-0214","volume":"171","author":"A Osswald","year":"2014","unstructured":"Osswald A, Plomer E, Dimopoulou C, Milian M, Blaser R, Ritzel K, Mickisch A, Knerr F, Stanojevic M, Hallfeldt MK, Schopohl J, Kuhn KA, Stalla G, Beuschlein F, Reincke M (2014) Favorable long-term outcomes of bilateral adrenalectomy in Cushing\u2019s disease. Eur J Endocrinol 171:209\u2013215","journal-title":"Eur J Endocrinol"},{"key":"640_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11102-012-0425-5","volume":"16","author":"N Alcalar","year":"2013","unstructured":"Alcalar N, Ozkan S, Kadioglu P, Celik O, Cagatay P, Kucukyuruk B, Gazioglu N (2013) Evaluation of depression, quality of life and body image in patients with Cushing\u2019s disease. Pituitary 16:333\u2013340","journal-title":"Pituitary"},{"key":"640_CR16","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3760\/cma.j.issn.0366-6999.20130944","volume":"126","author":"YF Chen","year":"2013","unstructured":"Chen YF, Li YF, Chen X, Sun Q-F (2013) Neuropsychiatric disorders and cognitive dysfunction in patients with Cushing\u2019s disease. Chin Med J 126:3156\u20133160","journal-title":"Chin Med J"},{"key":"640_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000338408","volume":"97","author":"C Dimopoulou","year":"2013","unstructured":"Dimopoulou C, Ising M, Pfister H, Schopohl J, Stalla GK, Sievers C (2013) Increased prevalence of anxiety-associated personality traits in patients with Cushing\u2019s disease: a cross-sectional study. Neuroendocrinol 97:139\u2013145","journal-title":"Neuroendocrinol"},{"key":"640_CR18","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Biermasz NR, Middelkoop HA, van der Mast RC, Romijn JA, Pereira AM (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95:E129\u2013E141","journal-title":"J Clin Endocrinol Metab"},{"key":"640_CR19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11102-012-0452-2","volume":"16","author":"R Pas van der","year":"2013","unstructured":"van der Pas R, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, de Jong FH, van der Lely AJ, de Herder WW, Webb SM, Lamberts SWJ, Hofland LJ, Feelders RA (2013) Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing\u2019s disease. Pituitary 16:536\u2013544","journal-title":"Pituitary"},{"key":"640_CR20","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1210\/jc.2013-1123","volume":"98","author":"MF Keil","year":"2013","unstructured":"Keil MF (2013) Quality of life and other outcomes in children treated for cushing syndrome. J Clin Endocrinol Metab 98:2667\u20132678","journal-title":"J Clin Endocrinol Metab"},{"key":"640_CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/cap.2012.0037","volume":"23","author":"O Malik","year":"2013","unstructured":"Malik O, Westphal B (2013) A role for selective serotonin reuptake inhibitors in the management of residual cognitive dysfunction in pediatric Cushing\u2019s disease. J Child Adolesc Psychopharm 23:65\u201369","journal-title":"J Child Adolesc Psychopharm"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0640-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-015-0640-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0640-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T23:23:23Z","timestamp":1717716203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-015-0640-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1007\/s11102-015-0640-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]}}}